Zepbound: Uses, Dosing, Results & Cost

Zepbound is the brand name for tirzepatide, a once-weekly injection made by Eli Lilly and approved by the FDA for chronic weight management. Zepbound is a dual GLP-1 and GIP receptor agonist, meaning it acts on two gut hormone pathways at once to reduce appetite and food noise. It is the same molecule as Mounjaro, which is the brand sold for type 2 diabetes.

This page is a hub. It gives you the big picture of what Zepbound is and who it is for, then points you to detailed articles on each part of treatment so you can go deeper wherever you need to. Zepbound is a prescription medicine, and any decision about starting, adjusting or stopping it should be made with a clinician who knows your health history. Think of the sections below as a map: skim the overview, then follow the link that matches the question on your mind, whether that is dosing, side effects, results or price.

Zepbound arrived as part of a new wave of obesity medicines that treat excess weight as a chronic medical condition rather than a matter of willpower. It is prescribed alongside a reduced-calorie eating plan and increased physical activity, not as a replacement for them. Because it works on the body's own appetite-regulating hormones, most people find that the changes to diet and habits they have struggled to sustain become far easier to maintain while on treatment.

Zepbound quick facts

Active ingredient	Tirzepatide
Drug class	Dual GLP-1 and GIP receptor agonist
Maker	Eli Lilly
How taken	Once-weekly subcutaneous injection
FDA-approved use	Chronic weight management; moderate-to-severe obstructive sleep apnea in adults with obesity
Doses	2.5, 5, 7.5, 10, 12.5 and 15 mg (maintenance is 5, 10 or 15 mg)
Average weight loss	About 20.9% of body weight at 15 mg over 72 weeks
List price per month	Roughly $1,086 before discounts

How Zepbound works

Zepbound activates both the GLP-1 and the GIP receptor. Together these signals reduce appetite, quiet the constant food noise many people describe, and slow how fast the stomach empties, so meals feel satisfying for longer and you naturally eat less. Because the effect depends on the drug being in your system, weight is often partly regained if treatment stops, which is why doctors treat obesity as a long-term condition. For a full walkthrough of the biology, read our explainer on how tirzepatide works.

Zepbound dosing

Treatment starts low and climbs slowly to let your body adjust and to limit stomach upset. The starter dose is 2.5 mg once weekly for four weeks, then 5 mg, with further increases of 2.5 mg no sooner than every four weeks, up to a maximum of 15 mg once weekly. Most people settle on a maintenance dose of 5, 10 or 15 mg. Our detailed guide to Zepbound dosage explains the full schedule, what to do about a missed dose and how the titration steps work.

Zepbound side effects

The most common side effects are gastrointestinal: nausea, diarrhea, vomiting and constipation. These tend to be worst early on and just after each dose increase, then ease as your body adapts. Zepbound also carries a boxed warning about thyroid C-cell tumors seen in animal studies, so it is not for people with a personal or family history of medullary thyroid cancer or MEN 2. The complete list, including rarer risks and warning signs to watch for, is in our article on Zepbound side effects.

Zepbound results and weight loss

Zepbound produces some of the largest weight loss seen with any obesity medicine to date. In the SURMOUNT-1 trial, adults on the 15 mg dose lost about 20.9% of their total body weight over 72 weeks, and many lost 25% or more at the top dose. That is higher than semaglutide, where Wegovy averaged around 15% in its trials. We break down what those numbers mean in practice in our overview of Zepbound weight loss results, and we dig into the study design and endpoints in Zepbound clinical trial results.

How much Zepbound costs

The list price is roughly $1,086 a month before any discounts, which is a real barrier for people paying out of pocket. Eli Lilly's LillyDirect pharmacy sells single-dose vials to eligible self-pay patients from about $349 to $499 a month depending on the dose. For a plain-language breakdown of what you might actually pay, see Zepbound cost per month, and compare the two brands of the same molecule in Zepbound and Mounjaro cost without insurance.

How Zepbound compares

Two comparisons come up constantly. The first is Zepbound versus Wegovy, the semaglutide brand, which pits a dual-hormone drug against a single GLP-1 medicine. See Wegovy vs Zepbound for the head-to-head on results, side effects and access. The second is more of a technicality: Mounjaro is the exact same tirzepatide molecule, just branded for diabetes, so people often ask which one they should be prescribed. Our Mounjaro vs Zepbound guide explains why the choice usually comes down to your diagnosis and insurance.

Zepbound for sleep apnea

Zepbound is not only a weight-loss drug. It is also FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity, making it the first medicine cleared for that use. If disrupted breathing at night is part of your picture, read Zepbound for sleep apnea to understand who qualifies and what the evidence shows.

Living with Zepbound day to day

Starting Zepbound changes ordinary routines in small ways. Alcohol can hit differently once your appetite and gut are on GLP-1 therapy, and our guide to GLP-1 medications and alcohol covers what to expect. Keeping a weekly injection cold and on schedule while away from home takes a little planning, which we walk through in traveling with GLP-1 medication. And because progress is steady rather than instant, it helps to frame the journey around realistic weight loss goals on GLP-1 therapy so you can measure success in a way that keeps you motivated.